Integrated Perspectives on Vascular Liver Disorders
Nov
10
2025
Convention Center: Room 146A, Level 1
2:00 PM
- 3:30 PM
World Class Speakers
Description
This session encompasses basic, translational, and clinical studies in vascular liver disease and portal hypertension, ranging from congestive hepatopathy and cirrhosis in Fontan-associated liver disease to intrahepatic moecular pathways of fibrosis in chronic liver disease. Key areas also include examination of porto-sinusoidal vascular liver disease and TIPS for acute and chronic portal vein thrombosis.Journey Maps
Presentations
3:00 PM
- 3:15 PM
May
18
2026
Washington, D.C.
Outcomes and Patency of TIPS for Portal Vein Thrombosis from the ALTA Study Group
Justin Boike, MD, MPH
, Abstract Presenter
Cirrhosis and Portal Hypertension
2:15 PM
- 2:30 PM
May
18
2026
Washington, D.C.
YAP contributes to liver fibrosis through mediating capillarization of liver sinusoidal endothelial cells via GATA6/eNOS signaling
Elizabeth C Verna, MD, MS, FAASLD
, Abstract Presenter
Cirrhosis and Portal Hypertension
2:30 PM
- 2:45 PM
May
18
2026
Washington, D.C.
Association between Liver Related Factors and Post- Cardiac Surgery Mortality
Riccardo Superina, MD
, Abstract Presenter
Cirrhosis and Portal Hypertension
Objectives
- Describe molecular mechanisms of fibrosis in vascular and chronic liver disease.
- Discuss mechanisms of hepatopathy in Fontan-associated liver disease as well as clinical implications after cardiac surgery.
- Evaluate the interactions of vascular liver disorders and portal hypertension, including the role of TIPS.